Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Antioxidants & Redox Signaling|February 24, 2015
Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces SynaptogenesisGerard Ill-Raga, Marta Tajes, Arnau Busquets-García, et al.
Journal of Medicinal Chemistry|October 13, 2006
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonistsBrett D Allison, Victor K Phuong, Laura C McAtee, et al.
Oncotarget|August 25, 2016
Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2α kinase in cortical neuronsEva Ramos-Fernández, Marta Tajes, Gerard Ill-Raga, et al.
Molecular Pharmacology|March 5, 2011
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitorTerrance D Barrett, Heather L Palomino, Theresa I Brondstetter, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin SecretagoguesMark D Rosen, Hariharan Venkatesan, Hillary M Peltier, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinasesJ G Conway, R C Andrews, B Beaudet, et al.
Combinatorial Chemistry & High Throughput Screening|August 17, 2005
Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mappingMillard H Lambert, R Kevin Blackburn, Theresa D Seaton, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitutionD L Musso, M W Andersen, R C Andrews, et al.
Nature Communications|June 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingSebastijan Hobor, Maise Al Bakir, Crispin T Hiley, et al.
Pageof 7